Virtual Library

Start Your Search

  • WCLC 2017

    18th World Conference on Lung Cancer

    Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan

    Presentation Date(s):  
    • Oct 15 - 18, 2017
    • Total Presentations: 2295

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Download PDF of the Conference Program: Click Here.
    Onsite Conference Program Addendum (17/10/2017): Click Here.
    Download PDF of the Abstract Book: Click Here.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    JCSE 01 - Joint IASLC/CSCO/CAALC Session: Immunotherapy for Management of Lung Cancer: Ongoing Research from East and West

    • Type: Joint Session IASLC/CSCO/CAALC
    • Track: Immunology and Immunotherapy
    • Presentations: 25
    • Moderators:C. Bai
    • Coordinates: 10/15/2017, 07:30 - 11:30, F203 (Annex Hall)
    • +

      JCSE 01.01 - Breakfast and Poster Viewing

      07:30 - 07:55

      • Abstract

      No abstract available for this presentation

    • +

      JCSE 01.02 - Welcome and Introduction

      07:55 - 08:00

      • Abstract

      No abstract available for this presentation

    • +

      JCSE 01.03 - The Science of Immunotherapy

      08:00 - 08:20  |  Presenter: Roy S. Herbst

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCSE 01.05 - PD-1+CD8+ T and iNKT Cell Based Immunotherapy on Lung Cancer

      08:20 - 08:40  |  Presenter: Jianqing Xu

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCSE 01.06 - ctDNA Based Tumor Mutation Burden Evaluation for Predicting Immunotherapy Effect

      08:40 - 09:00  |  Presenter: Jie Hu

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCSE 01.07 - Ongoing Trials in China on Checkpoint Inhibitors and Other Immunotherapies

      09:00 - 09:20  |  Presenter: Qing Zhou

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCSE 01.08 - Coffee Break and Poster Viewing

      09:20 - 09:45

      • Abstract

      No abstract available for this presentation

    • +

      JCSE 01.09 - Therapeutic Practices in Europe for Immunotherapy, including Biomarkers

      09:45 - 10:05  |  Presenter: Solange Peters

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCSE 01.10 - The Main Treatment Failure Pattern for Completely Resected Stage II–IIIA (N1–N2) EGFR-Mutation Positive Lung Cancer

      10:05 - 10:20  |  Presenter: Songtao Xu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCSE 01.11 - A Multicenter, Non-Interventional Study on Real World EGFR Testing and in Patients with IIIB/IV NSCLC in Northern China

      10:20 - 10:35  |  Presenter: Ying Cheng

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCSE 01.12 - A Phase II Study of Fruquintinib in Combination with Gefitinib in Stage IIIb/IV NSCLC Patients Harboring EGFR Activating Mutations

      10:35 - 10:50  |  Presenter: Shun Lu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCSE 01.13 - Discussant Oral Abstracts - JCSE 01.10, JCSE 01.11, JCSE 01.12

      10:50 - 11:10  |  Presenter: Joel W. Neal

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCSE 01.14 - Discussant Poster Abstracts

      11:10 - 11:30  |  Presenter: Bob T. Li

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCSE 01.15 - Next Generation Sequencing of Large-Cell Neuroendocrine Carcinoma Reveals an Association of PIK3CA Mutations with Brain Metastases

      11:30 - 11:30  |  Presenter: Mian Xie

      • Abstract

      Loading...

    • +

      JCSE 01.17 - The Correlation of DLL3 Expression with High-Grade Pulmonary Neuroendocrine Carcinoma Clinicopathologic Features and Prognose

      11:30 - 11:30  |  Author(s): Y. Liu

      • Abstract

      Loading...

    • +

      JCSE 01.18 - Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients

      11:30 - 11:30  |  Author(s): K. Chen

      • Abstract

      Loading...

    • +

      JCSE 01.20 - Primary Tumor Resection versus Maintenance Therapy for Patients with Oligometastatic Non-Small Cell Lung Cancer

      11:30 - 11:30  |  Presenter: Xiaozheng Kang

      • Abstract

      Loading...

    • +

      JCSE 01.21 - Combination of Biomarker and Clinicopathologic Characters May Circle out Beneficiaries through Second-Line Immunotherapy: A Meta Analyse

      11:30 - 11:30  |  Presenter: Si-Yang Liu

      • Abstract

      Loading...

    • +

      JCSE 01.23 - The Feasibility of Osimertinib Treatment on Brain Metastases in NSCLC Patients After 1st Generation EGFR-TKI Resistance: A Preliminary Study

      11:30 - 11:30  |  Presenter: Lucheng Zhu

      • Abstract

      Loading...

    • +

      JCSE 01.24 - Detection of EGFR, ALK and Other Driver Oncogenes from Plasma cfDNA by Single Molecule Amplification and Re-sequencing Technology (cSMART)

      11:30 - 11:30  |  Presenter: Tony SK Mok

      • Abstract

      Loading...

    • +

      JCSE 01.25 - Detection of EGFR T790M Mutations by Four Testing Platforms in ctDNA from Chinese Patients with Advanced NSCLC

      11:30 - 11:30  |  Presenter: Xu-Chao Zhang

      • Abstract

      Loading...

    • +

      JCSE 01.26 - Circulating Cell-Free DNA of Cerebrospinal Fluid May Function as Liquid Biopsy for Leptomeningeal Metastases of ALK Rearrangement NSCLC

      11:30 - 11:30  |  Presenter: Yangsi Li

      • Abstract

      Loading...

    • +

      JCSE 01.27 - Patients with ALK IHC-Positive/FISH-Negative NSCLC Benefit from ALK TKI Treatment: Response Data from the Global ALEX Trial

      11:30 - 11:30  |  Presenter: Tony SK Mok

      • Abstract

      Loading...

    • +

      JCSE 01.28 - NGS Sequencing Based Liquid / Tissue Biopsy Identified Coexistence of HER2 Amplification and Mutation in Advanced NSCLC Patients

      11:30 - 11:30  |  Presenter: Rongrong Chen

      • Abstract

      Loading...

    • +

      JCSE 01.29 - Closing Remarks

      11:30 - 11:30

      • Abstract

      No abstract available for this presentation

  • +

    P1.01 - Advanced NSCLC

    • Type: Poster Session with Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 80
    • Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P1.01-009 - Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Jin Kang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.01-010 - Circulating Cell-Free DNA of Cerebrospinal Fluid May Function as Liquid Biopsy for Leptomeningeal Metastases of ALK Rearrangement NSCLC

      09:30 - 09:30  |  Presenter: Yangsi Li

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.01-018 - Acquired Resistance to Crizotinib in Advanced NSCLC with De Novo MET Overexpression

      09:30 - 09:30  |  Presenter: Anna Li

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.01-027 - Combination of Biomarker and Clinicopathologic Characters May Circle out Beneficiaries through Second-Line Immunotherapy: A Meta Analyse

      09:30 - 09:30  |  Presenter: Si-Yang Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.01-032 - Detection of EGFR, ALK and Other Driver Oncogenes from Plasma cfDNA by Single Molecule Amplification and Re-sequencing Technology (cSMART)

      09:30 - 09:30  |  Presenter: Tony SK Mok

      • Abstract

      Loading...

  • +

    P1.04 - Clinical Design, Statistics and Clinical Trials

    • Type: Poster Session with Presenters Present
    • Track: Clinical Design, Statistics and Clinical Trials
    • Presentations: 13
    • Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P1.04-010 - CheckMate 870: An Open-label Safety Study of Nivolumab in Previously Treated Patients With Non-Small Cell Lung Cancer in Asia

      09:30 - 09:30  |  Presenter: Shun Lu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.07 - Immunology and Immunotherapy

    • Type: Poster Session with Presenters Present
    • Track: Immunology and Immunotherapy
    • Presentations: 48
    • Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P1.07-042 - PD-L1 and CD8 Expression in EGFR-Mutant or ALK-Rearranged Patients with Lung Cancer

      09:30 - 09:30  |  Author(s): S. Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.13 - Radiology/Staging/Screening

    • Type: Poster Session with Presenters Present
    • Track: Radiology/Staging/Screening
    • Presentations: 15
    • Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P1.13-001 - T1 Tumor(≪3cm) with Visceral Pleural Invasion Should Be Classified as T2a in the 8th TNM Classification for Lung Cancer

      09:30 - 09:30  |  Presenter: Jia-Tao Zhang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA 05 - Next Generation TKI

    • Type: Oral
    • Track: Advanced NSCLC
    • Presentations: 9
    • +

      OA 05.01 - First-Line Dacomitinib versus Gefitinib in Advanced Non-Small-Cell Lung Cancer with EGFR Mutation Subgroups

      15:45 - 15:55  |  Presenter: Yi-Long Wu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.03 - Chemotherapy/Targeted Therapy

    • Type: Poster Session with Presenters Present
    • Track: Chemotherapy/Targeted Therapy
    • Presentations: 59
    • Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P2.03-047 - The Main Treatment Failure Pattern for Completely Resected Stage II–IIIA (N1–N2) EGFR-Mutation Positive Lung Cancer

      09:30 - 09:30  |  Presenter: Songtao Xu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P2.03-054 - EGFR Mutation with Acquired C-MET Positive Reveals Potential Immunotherapeutic Vulnerabilities

      09:30 - 09:30  |  Presenter: Shan Su

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.04 - Clinical Design, Statistics and Clinical Trials

    • Type: Poster Session with Presenters Present
    • Track: Clinical Design, Statistics and Clinical Trials
    • Presentations: 14
    • Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P2.04-006 - ADAURA: PhIII, Double-Blind, Randomized Study of Osimertinib vs Placebo in EGFR Mutation-Positive NSCLC Post-Tumor Resection

      09:30 - 09:30  |  Presenter: Roy S. Herbst

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P2.04-012 - First-Line Ensartinib (X396) versus Crizotinib in Advanced ALK-Rearranged NSCLC (eXalt3): A Randomized, Open-Label, Phase 3 Study

      09:30 - 09:30  |  Presenter: Yi-Long Wu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.08 - Locally Advanced Nsclc

    • Type: Poster Session with Presenters Present
    • Track: Locally Advanced NSCLC
    • Presentations: 7
    • Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P2.08-002 - A Nomogram for Predicting Underlying Beneficiaries for Resectable IIIA/N2 NSCLC Patients

      09:30 - 09:30  |  Presenter: Chao Zhang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA 11 - Emerging Diagnostic/Biomarkers in NSCLC

    • Type: Mini Oral
    • Track: Advanced NSCLC
    • Presentations: 12
    • Moderators:M.I. Abdul Wahid
    • Coordinates: 10/17/2017, 11:00 - 12:30, Room 313 + 314
    • +

      MA 11.03 - Gefitinib as First-Line Treatment of Plasma CtDNA EGFR Mutation-Positive NSCLC Detected by DdPCR: BENEFIT Study (CTONG1405)

      11:10 - 11:15  |  Presenter: Jie Wang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.